Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Atai Life Sciences N.V. (ATAI)

Atai Life Sciences N.V. (ATAI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,494,520
  • Shares Outstanding, K 152,570
  • Annual Sales, $ 190 K
  • Annual Income, $ 124,340 K
  • 60-Month Beta N/A
  • Price/Sales 127.33
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade ATAI with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/16/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 71.24%
  • Historical Volatility 51.96%
  • IV Percentile 13%
  • IV Rank 8.47%
  • IV High 142.96% on 07/08/21
  • IV Low 64.60% on 08/05/21
  • Put/Call Vol Ratio 0.77
  • Today's Volume 291
  • Volume Avg (30-Day) 351
  • Put/Call OI Ratio 0.86
  • Today's Open Interest 1,831
  • Open Int (30-Day) 5,954

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.31
  • Number of Estimates 2
  • High Estimate -0.15
  • Low Estimate -0.46
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.03%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.85 +11.72%
on 09/16/21
17.90 -7.32%
on 09/08/21
+0.53 (+3.30%)
since 08/23/21
3-Month
13.13 +26.35%
on 08/16/21
20.45 -18.88%
on 07/13/21
-1.79 (-9.74%)
since 06/23/21

Most Recent Stories

More News
This Game-Changing Drug Could Help the Billions Struggling with Obesity

Psychedelics, like psilocybin could soon revolutionize the treatment of mental and health issues, including ...

NMDBF : 0.0824 (+8.14%)
ATAI : 16.59 (+1.47%)
MNMD : 2.51 (+2.87%)
HAVN.CN : 0.300 (-3.23%)
HAVLF : 0.2350 (-2.08%)
MYCOF : 0.2766 (+0.29%)
MYCO.CN : 0.400 (-6.98%)
NEON.CN : 0.105 (+5.00%)
Psychedelics -- Not Just for Mental Health Anymore

/PRNewswire/ -- In , Congress created what is known as Breakthrough Therapy designation, a distinction that affords biotechnology and pharmaceutical companies an expedited review process for experimental...

ATAI : 16.59 (+1.47%)
TRYP.CN : 0.420 (+15.07%)
TRYPF : 0.3350 (+16.68%)
CMPS : 32.28 (+2.09%)
MNMD : 2.51 (+2.87%)
CYBN : 2.24 (+5.16%)
CLXPF : 3.0200 (-1.31%)
This Drug Could Soon Help Millions Battling the Obesity Epidemic

The obesity epidemic in the U.S. is only getting worse. In fact, by the time 2030 rolls around, nearly ...

NMDBF : 0.0824 (+8.14%)
ATAI : 16.59 (+1.47%)
MNMD : 2.51 (+2.87%)
COPHF : 0.0770 (-6.10%)
PHRRF : 0.6334 (-1.65%)
PHRM.CN : 0.800 (-1.23%)
NEON.CN : 0.105 (+5.00%)
3 Pyschedelic Stocks That Investors Should Keep on Their Radars

ATAI Life Sciences N.V (ATAI), Compass Pathways Plc (CMPS), and Mind Medicine Holdings (MNMD) are 3 stocks that are looking to commercialize psychedelics for medical use. Investors should keep them on...

ATAI : 16.59 (+1.47%)
CMPS : 32.28 (+2.09%)
MNMD : 2.51 (+2.87%)
Leading U.S.-Based Psychedelic Healthcare VC Fund Launches with $35 Million Raised to Tackle the Growing Global Mental Health Crisis

/PRNewswire/ -- , the leading U.S.-based psychedelic investment fund, announced its launch with an initial in capital raised and an active portfolio of 20 companies. The diversified venture fund is focused...

ATAI : 16.59 (+1.47%)
Psychedelic Decriminalization Creating Market Opportunities

/PRNewswire/ --What was once a war on drugs has turned into a public push for the decriminalization and legalization of illegal drugs with potential therapeutic benefits. Legalization efforts began with ...

MNMD : 2.51 (+2.87%)
CYBN : 2.24 (+5.16%)
CMPS : 32.28 (+2.09%)
ATAI : 16.59 (+1.47%)
NUMI.VN : 0.830 (-1.19%)
Rising Prevalence of Mental Depression & Anxiety Major Drivers Propelling Demand In Psychedelic Drugs Market

/PRNewswire/ -- Psychedelic drugs and therapies are truly becoming mainstream and are expected to become even more so in the years to come. Psychedelic drugs involve various types of chemical substances...

OPTI.CN : 0.600 (unch)
OPTHF : 0.4820 (+2.55%)
MNMD : 2.51 (+2.87%)
CMPS : 32.28 (+2.09%)
ATAI : 16.59 (+1.47%)
CLXPF : 3.0200 (-1.31%)
CYBN : 2.24 (+5.16%)
GTMS.TO : 9.50 (-19.83%)
GBNH : 7.40 (unch)
GW Pharma Sells for Billions; Psychedelic Company Following Similar Path

/PRNewswire/ -- In ,  listed on Nasdaq, selling 3.5 million shares at each to investors betting that GW was charting a profitable course as a biotech developing new drugs from cannabis-derived compounds....

ATAI : 16.59 (+1.47%)
TRYP.CN : 0.420 (+15.07%)
TRYPF : 0.3350 (+16.68%)
CMPS : 32.28 (+2.09%)
MNMD : 2.51 (+2.87%)
JAZZ : 131.80 (+1.74%)
Healthy Living: Here’s What’s Driving the Mushroom Boom

Mushrooms seem to be popping up everywhere these days. All as millions digest the idea that mushrooms ...

ATAI : 16.59 (+1.47%)
CMPS : 32.28 (+2.09%)
MYCOF : 0.2766 (+0.29%)
CYBN : 2.24 (+5.16%)
CLXPF : 3.0200 (-1.31%)
NMDBF : 0.0824 (+8.14%)
NEON.CN : 0.105 (+5.00%)

Business Summary

atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.

See More

Key Turning Points

3rd Resistance Point 17.07
2nd Resistance Point 16.75
1st Resistance Point 16.55
Last Price 16.59
1st Support Level 16.03
2nd Support Level 15.71
3rd Support Level 15.51

See More

52-Week High 22.91
Fibonacci 61.8% 19.17
Fibonacci 50% 18.02
Fibonacci 38.2% 16.87
Last Price 16.59
52-Week Low 13.13

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar